In addition to having the glucagon-producing cells produce insulin, the study also showed that these cells were also more resistant against the immune system, which usually attacks insulin-producing cells in diabetes patients.
“This means that we probably can use the patient’s own cells in this diabetestreatment, without being afraid that the manipulated cells will eventually be destroyed by the immune system,” Ræder explains.
“Today, it is possible to transplant insulin producing cells from dead donors to diabetes patients. The big challenge is that we are only able to treat a very small fraction of the patients with this method.”
Ræder believes that the new method is not limited to only changing the function of the cells in the pancreas. He thinks that this cell flexibility will be found in many other types of cells in the human body, and may contribute to new treatments for many different diseases.
“The ability of cells to change their function may be important in the treatment of other diseases caused by cell death, including neurological diseases, heart attacks and cancer,” says Helge Ræder.
Facts: Diabetes and pancreas:
- There are three different types of cells in the pancreas: alpha-cells, beta-cells and delta-cells. The cells make cluster and produce different kinds of hormones for blood sugar regulation.
- Alpha-cells produce glucagon, which increases the blood sugar levels. Beta-cells produce insulin, which decreases glucagon levels. Delta-cells produce somatostatin, which controls the regulation of the Alpha and Beta Cells.
- Persons with type I diabetes have a damaged beta-cell function, and therefore have constant high blood sugar levels. They need to get insulin by injections.